New heart failure pill shows promise in early trial
Disease control
Completed
This study tested a new drug called JTT-861 in 314 adults with chronic heart failure and reduced pumping ability. Participants took either the drug or a placebo once daily for 12 weeks, alongside their usual heart medications. The goal was to see if the drug improves heart functi…
Phase: PHASE2 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC